Related Experiment Video
Updated: Jul 15, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Sequential regression and simulation: a method for estimating causal effects from heterogeneous clinical trials
Vivek A Rudrapatna1,2, Vignesh G Ravindranath3, Douglas V Arneson3
1Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. vivek.rudrapatna@ucsf.edu.
A new meta-analysis method allows combining clinical trial data without common controls. This approach enables new discoveries from existing data, even with heterogeneous studies, advancing medical research.
Area of Science:
- Clinical trial data analysis
- Biostatistics
- Pharmacoeconomics
Background:
- Clinical trial data sharing platforms offer opportunities for novel discoveries.
- Existing meta-analysis methods are limited by the requirement for shared control groups.
- A new method is needed to meta-analyze heterogeneous clinical trials lacking common control groups.
Purpose of the Study:
- To develop a novel method for meta-analyzing heterogeneous clinical trials without a common control group.
- To address limitations in current meta-analysis techniques for clinical trial data.
- To enable broader research questions using existing clinical trial data.
Main Methods:
- Developed a method using sequential regression and simulation.
- Modeled placebo- and drug-attributable effects separately.
- Simulated head-to-head trials against a normalized background.
- Validated the method by comparing simulated adalimumab vs. ustekinumab trial with SEAVUE results.
Main Results:
- The novel method successfully replicated published results from the SEAVUE trial comparing adalimumab and ustekinumab.
- Primary analysis showed no significant difference between simulated and actual trial outcomes (p=0.9).
- Findings remained stable across multiple sensitivity analyses.
Conclusions:
- The developed method facilitates meta-analysis of heterogeneous clinical trials lacking common control groups.
- This approach can reduce bias in individual participant data meta-analyses.
- It expands the scope of research from existing data and lowers evidence-generation costs.
Related Concept Videos
Causality in Epidemiology
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Randomized Experiments
Simple randomization
Simple...
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Comparing the Survival Analysis of Two or More Groups
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.

